TY - JOUR
T1 - Unexpected frequency of the pathogenic AR CAG repeat expansion in the general population
AU - The American Genome Center (TAGC) consortium
AU - Genomics England Research Consortium
AU - Project MinE ALS Sequencing Consortium
AU - The NYGC ALS Consortium
AU - Zanovello, Matteo
AU - Ibáñez, Kristina
AU - Brown, Anna Leigh
AU - Sivakumar, Prasanth
AU - Bombaci, Alessandro
AU - Santos, Liana
AU - van Vugt, Joke J.F.A.
AU - Narzisi, Giuseppe
AU - Karra, Ramita
AU - Scholz, Sonja W.
AU - Ding, Jinhui
AU - Gibbs, J. Raphael
AU - Chiò, Adriano
AU - Dalgard, Clifton
AU - Weisburd, Ben
AU - Hanna, Michael G.
AU - Greensmith, Linda
AU - Phatnani, Hemali
AU - Veldink, Jan H.
AU - Traynor, Bryan J.
AU - Polke, James
AU - Houlden, Henry
AU - Fratta, Pietro
AU - Tucci, Arianna
N1 - Publisher Copyright:
© The Author(s) 2023. Published by Oxford University Press on behalf of the Guarantors of Brain.
PY - 2023/7/1
Y1 - 2023/7/1
N2 - CAG repeat expansions in exon 1 of the AR gene on the X chromosome cause spinal and bulbar muscular atrophy, a male-specific progressive neuromuscular disorder associated with a variety of extra-neurological symptoms. The disease has a reported male prevalence of approximately 1:30 000 or less, but the AR repeat expansion frequency is unknown. We established a pipeline, which combines the use of the ExpansionHunter tool and visual validation, to detect AR CAG expansion on whole-genome sequencing data, benchmarked it to fragment PCR sizing, and applied it to 74 277 unrelated individuals from four large cohorts. Our pipeline showed sensitivity of 100% [95% confidence interval (CI) 90.8–100%], specificity of 99% (95% CI 94.2–99.7%), and a positive predictive value of 97.4% (95% CI 84.4–99.6%). We found the mutation frequency to be 1:3182 (95% CI 1:2309–1:4386, n = 117 734) X chromosomes—10 times more frequent than the reported disease prevalence. Modelling using the novel mutation frequency led to estimate disease prevalence of 1:6887 males, more than four times more frequent than the reported disease prevalence. This discrepancy is possibly due to underdiagnosis of this neuromuscular condition, reduced penetrance, and/or pleomorphic clinical manifestations.
AB - CAG repeat expansions in exon 1 of the AR gene on the X chromosome cause spinal and bulbar muscular atrophy, a male-specific progressive neuromuscular disorder associated with a variety of extra-neurological symptoms. The disease has a reported male prevalence of approximately 1:30 000 or less, but the AR repeat expansion frequency is unknown. We established a pipeline, which combines the use of the ExpansionHunter tool and visual validation, to detect AR CAG expansion on whole-genome sequencing data, benchmarked it to fragment PCR sizing, and applied it to 74 277 unrelated individuals from four large cohorts. Our pipeline showed sensitivity of 100% [95% confidence interval (CI) 90.8–100%], specificity of 99% (95% CI 94.2–99.7%), and a positive predictive value of 97.4% (95% CI 84.4–99.6%). We found the mutation frequency to be 1:3182 (95% CI 1:2309–1:4386, n = 117 734) X chromosomes—10 times more frequent than the reported disease prevalence. Modelling using the novel mutation frequency led to estimate disease prevalence of 1:6887 males, more than four times more frequent than the reported disease prevalence. This discrepancy is possibly due to underdiagnosis of this neuromuscular condition, reduced penetrance, and/or pleomorphic clinical manifestations.
KW - androgen receptor
KW - bioinformatics
KW - bulbar muscular atrophy
KW - population genetics
KW - spinal
KW - whole-genome sequencing
UR - http://www.scopus.com/inward/record.url?scp=85164209619&partnerID=8YFLogxK
U2 - 10.1093/brain/awad050
DO - 10.1093/brain/awad050
M3 - Article
C2 - 36797998
AN - SCOPUS:85164209619
SN - 0006-8950
VL - 146
SP - 2723
EP - 2729
JO - Brain
JF - Brain
IS - 7
ER -